These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 37500513)

  • 1. Sugar-Sweetened and Artificially Sweetened Beverages and Risk of Liver Cancer and Chronic Liver Disease Mortality.
    Zhao L; Zhang X; Coday M; Garcia DO; Li X; Mossavar-Rahmani Y; Naughton MJ; Lopez-Pentecost M; Saquib N; Shadyab AH; Simon MS; Snetselaar LG; Tabung FK; Tobias DK; VoPham T; McGlynn KA; Sesso HD; Giovannucci E; Manson JE; Hu FB; Tinker LF; Zhang X
    JAMA; 2023 Aug; 330(6):537-546. PubMed ID: 37552302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Life's Essential 8 with incident atherosclerotic cardiovascular disease in cancer patients: the Kailuan prospective cohort study.
    Zhang N; Wei Z; Zhang Y; Zhang Q; Chen Z; Tse G; Li G; Liu T; Wu S
    Eur J Prev Cardiol; 2023 Nov; 30(17):e78-e80. PubMed ID: 37527528
    [No Abstract]   [Full Text] [Related]  

  • 3. Emerging concepts in the detection of liver fibrosis in non-alcoholic fatty liver disease.
    Armandi A; Michel M; Gjini K; Emrich T; Bugianesi E; Schattenberg JM
    Expert Rev Mol Diagn; 2023; 23(9):771-782. PubMed ID: 37505901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel predictors of early atherosclerosis in nonalcoholic fatty liver disease.
    Abdulaziz BA; Bendary AM; Thabet A; Behery EG; Salah M; Khalil MA; Rashad G
    Clin Exp Hepatol; 2023 Jun; 9(2):106-114. PubMed ID: 37502438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to Mediterranean Diet: Any Association with NAFLD?
    Barrea L; Verde L; Savastano S; Colao A; Muscogiuri G
    Antioxidants (Basel); 2023 Jun; 12(7):. PubMed ID: 37507858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-12 modulates Kupffer cell polarization to alter the progression of nonalcoholic fatty liver disease.
    Lee JL; Wang YC; Hsu YA; Chen CS; Weng RC; Lu YP; Chuang CY; Wan L
    Glycobiology; 2023 Oct; 33(8):673-682. PubMed ID: 37504513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin E supplementation in the treatment on nonalcoholic fatty liver disease (NAFLD): Evidence from an umbrella review of meta-analysis on randomized controlled trials.
    Wang MY; Prabahar K; Găman MA; Zhang JL
    J Dig Dis; 2023; 24(6-7):380-389. PubMed ID: 37503812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of decompensated cirrhosis in children: A population-based study.
    Kehar M; Griffiths R; Flemming JA
    Can Liver J; 2023 Jul; 6(2):278-282. PubMed ID: 37503518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant roles of potential genes and their mutations in nonalcoholic fatty liver disease.
    Sokouti B
    Clin Exp Hepatol; 2023 Jun; 9(2):95-105. PubMed ID: 37502439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of body composition and liver function after long-term pemafibrate treatment on dyslipidemia-associated non-alcoholic fatty liver disease.
    Ishikawa T; Terai N; Igarashi T; Yamazaki S; Kobayashi T; Sato T; Iwanaga A; Sano T; Yokoyama J; Honma T
    Clin Exp Hepatol; 2023 Jun; 9(2):172-178. PubMed ID: 37502434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermoneutral housing promotes hepatic steatosis in standard diet-fed C57BL/6N mice, with a less pronounced effect on NAFLD progression upon high-fat feeding.
    Horakova O; Sistilli G; Kalendova V; Bardova K; Mitrovic M; Cajka T; Irodenko I; Janovska P; Lackner K; Kopecky J; Rossmeisl M
    Front Endocrinol (Lausanne); 2023; 14():1205703. PubMed ID: 37501785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the habitual dietary intake with the fatty liver index and effect modification by metabotypes in the population-based KORA-Fit study.
    Schepp M; Freuer D; Wawro N; Peters A; Heier M; Teupser D; Meisinger C; Linseisen J
    Lipids Health Dis; 2024 Apr; 23(1):99. PubMed ID: 38575962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultra-processed food consumption and the risk of non-alcoholic fatty liver disease in the Tianjin Chronic Low-grade Systemic Inflammation and Health Cohort Study.
    Zhang S; Gan S; Zhang Q; Liu L; Meng G; Yao Z; Wu H; Gu Y; Wang Y; Zhang T; Wang X; Sun S; Wang X; Zhou M; Jia Q; Song K; Qi L; Niu K
    Int J Epidemiol; 2022 Feb; 51(1):237-249. PubMed ID: 34528679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to the Dietary Approaches to Stop Hypertension (DASH) diet is associated with lower presence of non-alcoholic fatty liver disease in middle-aged and elderly adults.
    Xiao ML; Lin JS; Li YH; Liu M; Deng YY; Wang CY; Chen YM
    Public Health Nutr; 2020 Mar; 23(4):674-682. PubMed ID: 31566148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Egg consumption and risk of non-alcoholic fatty liver disease.
    Mokhtari Z; Poustchi H; Eslamparast T; Hekmatdoost A
    World J Hepatol; 2017 Apr; 9(10):503-509. PubMed ID: 28443155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Egg consumption and non-alcoholic fatty liver disease: a prospective cohort study].
    Yin M; Chen S; Sun Y; Feng B; Lan Y; Wu S; Wang L
    Wei Sheng Yan Jiu; 2023 May; 52(3):362-368. PubMed ID: 37500513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to the dietary approaches to stop hypertension diet and non-alcoholic fatty liver disease.
    Sun Y; Chen S; Zhao X; Wang Y; Lan Y; Jiang X; Gao X; Wu S; Wang L
    Liver Int; 2022 Apr; 42(4):809-819. PubMed ID: 34990079
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.